Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients

Jay Shavadia,DaJuanicia N. Holmes,Laine Thomas,Eric D. Peterson,Christopher B. Granger,Matthew T. Roe,Tracy Y. Wang

Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients

2019

Jay Shavadia
DaJuanicia N. Holmes
Laine Thomas
Eric D. Peterson
Christopher B. Granger
Matthew T. Roe
Tracy Y. Wang

Background: The benefit of β-blocker use beyond 3 years after a myocardial infarction (MI) has not been clearly determined. Methods and Results: Using data from the CRUSADE Registry (Can Rapid Risk...

Keywords:

Physical therapy
Medicine
Myocardial infarction
Stroke
Heart failure
Cardiology
Internal medicine
Emergency medicine
long term outcomes

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations